Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2019, Vol. 24 ›› Issue (11): 1310-1314.doi: 10.12092/j.issn.1009-2501.2019.11.016

Previous Articles     Next Articles

Research progress of endoplasmic reticulum stress in heart diseases

WANG Kaiyang 1, LI Xiaoli 2,3, CAI Yongqing4   

  1. 1 Drug and Equipment Department,NO.927 Hospital,Joint Logistics Support Force of Chinese PLA,Puer 665000,Yunnan,China; 2 Department of Pharmacology,College of Pharmacy,Chongqing University of Medical Sciences,Chongqing 400016,China; 3 Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016,China; 4 Department of Pharmacy,Army Medical Center of PLA, Chongqing 400042,China
  • Received:2019-06-18 Revised:2019-09-11 Online:2019-11-26 Published:2019-12-02

Abstract:

Endoplasmic reticulum is an important organelle for intracellular protein processing and modification.It produces a series of reactions, including unfolded protein reactions, to maintain intracellular homeostasis and protein quality control.The accumulation of unfolded or misfolded proteins in endoplasmic reticulum will further lead to endoplasmic reticulum stress and cell and organism dysfunction.Recent studies have found that endoplasmic reticulum stress is highly related to the occurrence and development of various heart diseases.This article reviews the role of endoplasmic reticulum stress in the occurrence and development of ischemic heart disease,primary cardiomyopathy,myocardial hypertrophy and heart failure.Based on the mechanism of endoplasmic reticulum stress in cardiac diseases,it can provide theoretical basis and application means for the treatment of cardiac diseases by targeting endoplasmic reticulum stress.

Key words: endoplasmic reticulum stress, heart diseases, targeting

CLC Number: